We’re a collaboration of partners, founders, and researchers tackling healthcare’s biggest challenges.

A Venture Capital Team

Helping Founders Build the Future

Together we work in service of patients everywhere to advance the therapeutic potential of controlled substances through science, entrepreneurship, and policy.

– Ross O’Brien, Managing Partner

Beyond the Headlines

BVE Insights

C

Featured

Explore All Insights

Filter or search all BVE Insights ▾

Filter or search all BVE Insights ▾

Filter by category:

Filter by category:
  • All
  • Breaking (1)
  • In Context (1)
  • Insight (1)
  • Q&A (1)

Filter by type of media:

Filter by type of media:
  • All
  • Article (4)

Narrow by keyword and/or date:

Narrow by keyword and/or date:

Narrow by date:

Narrow by date:
Subheading

Portfolio

C

First company to map the genome of the Cannabis plant
First A.I. in-silica development of an anxiety drug candidate
First company to reach the kilogram scale of synthetic CBD
First patents for treating neurodegenerative disease co-authored with the Salk Institute
Incubating first IP development & technology transfer partnership
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Scroll to Top

Sign up form